Neo Performance Materials Reports First Quarter 2023 Results

Q1 2023 Highlights
(unless otherwise noted, all financial amounts in this news release are expressed in U.S. dollars)

• Q1 2023 revenue of $135.5 million.
• Operating loss of $4.0 million in the quarter.
• Adjusted Net Loss⁽¹⁾ of $9.0 million, or $(0.19) per share.
• Adjusted EBITDA⁽¹⁾ of $0.8 million which included a charge of $5.6 million for inventories during the quarter.
• Cash balance of $145.7 million after distributing $3.4 million in dividends to shareholders, a net cash improvement of $12.2 million from December 31, 2022.
• On April 19, 2023, Neo announced the completion of its acquisition of 90% of the outstanding share capital of SG Technologies Group Limited ("SGTec"), one of Europe's leading advanced, specialty manufacturers of rare-earth-based and other high-performance magnets for industrial and commercial markets.
• On April 24, 2023, Neo announced that the Government of Greenland had approved the transfer of an exploration license covering a portion of the Sarfartoq Carbonatite Complex in southwest Greenland, a prospective magnetic rare earth property, from Hudson Resources, Inc. to Neo North Star Resources Inc. ("NNSR"), a subsidiary controlled by Neo, and that purchase of the license has been completed. The License has been transferred to NNSR, on May 3, 2023, upon endorsement of a license addendum by the government of Greenland.
• A quarterly dividend of Cdn$0.10 per common share was declared on May 10, 2023 for shareholders of record at June 20, 2023, with a payment date of June 29, 2023.

TORONTO, May 12, 2023 /CNW/ - Neo Performance Materials Inc. ("Neo", the "Company") (TSX: NEO) released its first quarter 2023 financial results. The financial statements and management's discussion and analysis ("MD&A") of these results can be viewed on Neo's web site at www.neomaterials.com/investors/ and on SEDAR at www.sedar.com.

___________________________

⁽¹⁾ Neo reports non-IFRS measures such as "Adjusted Net Income", "Adjusted Earnings per Share", "Adjusted EBITDA", "Adjusted EBITDA Margin" and "EBITDA". Please see information on this and other non-IFRS measures in the "Non-IFRS Measures" section of this new release and in the MD&A, available on Neo's website at www.neomaterials.com and on SEDAR at www.sedar.com.

HIGHLIGHTS OF Q1 2023

For the three months ended March 31, 2023, consolidated revenue was $135.5 million compared to $166.3 million for the same period in the prior year.  Neo reported a net loss of $10.7 million, or $(0.23) per share, compared to a net income of $22.7 million, or $0.55 per share, in the same period of 2022.  Adjusted Net Loss⁽¹⁾ totaled $9.0 million, or $(0.19) per share, compared to an Adjusted Net Income⁽¹⁾ of $23.5 million, or $0.57 per share, in the corresponding period of the prior year.  Adjusted EBITDA⁽¹⁾ was $0.8 million, compared to Adjusted EBITDA⁽¹⁾ of $33.1 million in the first quarter of 2022.  Adjusted EBITDA⁽¹⁾ for the three months ended March 31, 2023 was negatively impacted by $5.6 million of provisions for inventories during the quarter, compared to $0.6 million during the corresponding period in 2022.

As of March 31, 2023, Neo had cash and cash equivalents of $145.7 million plus restricted cash of $1.2 million, compared to $147.5 million plus $1.2 million as at December 31, 2022.  In the three months ended March 31, 2023, Neo distributed $3.4 million in dividends to its shareholders.  Neo generated positive net cash of $12.2 million in the period.

SELECTED FINANCIAL RESULTS

TABLE 1: Selected Consolidated Results
	Year-over-Year Comparison
($000s)	Q1 2023	Q1 2022
Revenue	135,530	166,282
Operating (loss) income	(3,997)	28,685
EBITDA^(1)	(1,144)	33,384
Adjusted EBITDA^(1)	787	33,118
Adjusted EBITDA Margin %^(1)	0.6 %	19.9 %

_________________________

⁽¹⁾Neo reports non-IFRS measures such as "Adjusted Net Income", "Adjusted Earnings per Share", "Adjusted EBITDA", "Adjusted EBITDA Margin" and "EBITDA". Please see information on this and other non-IFRS measures in the "Non-IFRS Measures" section of this news release and in the MD&A.

Neo reported operating loss of $4.0 million and net loss of $10.7 million for the three months ended March 31, 2023. Operating income in the three months ended March 31, 2023, was higher as compared to the prior-year period in the Rare Metals segment but was lower in both the Magnequench and C&O segments.

Adjusted EBITDA^(I) also was higher in the quarter as compared to the prior-year period in Rare Metals but was lower in C&O and Magnequench.

_______________________________

⁽¹⁾Neo reports non-IFRS measures such as "Adjusted Net Income", "Adjusted Earnings per Share", "Adjusted EBITDA", "Adjusted EBITDA Margin" and "EBITDA". Please see information on this and other non-IFRS measures in the "Non-IFRS Measures" section of this new release and in the MD&A, available on Neo's website at www.neomaterials.com and on SEDAR at www.sedar.com.

MAGNEQUENCH SEGMENT RESULTS

TABLE 2: Selected Magnequench Results
	Year-over-Year Comparison
	Q1 2023	Q1 2022
Volume (tonnes)	987	1,305
($000s)
Revenue	55,165	74,015
Operating income	955	10,236
EBITDA^(1)	3,227	13,547
Adjusted EBITDA^(1)	3,256	12,778

_________________________

⁽¹⁾Neo reports non-IFRS measures such as "Adjusted Net Income", "Adjusted Earnings per Share", "Adjusted EBITDA", "Adjusted EBITDA Margin" and "EBITDA". Please see information on this and other non-IFRS measures in the "Non-IFRS Measures" section of this news release and in the MD&A.

Volumes in the three months ended March 31, 2023 were lower primarily due to the impact of slower economic activity in China which experienced a slowdown after the removal of the COVID-19 zero tolerance from December 2022.  This lower economic activity (particularly in durable goods) continued through the balance of the quarter.  Volumes were also negatively impacted by the continued semi-conductor chip shortages, primarily in the automotive industry. 

Margins for Magnequench were lower in the quarter due to the decline in rare earth magnetic prices in the quarter and lower volume affecting absorption of production costs.  Magnequench has pass-through agreements on the vast majority of its contracts so that in the long term, Magnequench expects to earn steadier margins on its value-add conversion activities.  However, in the first quarter of 2023, with declining rare earth magnetic prices, Magnequench has been passing through the lower replacement costs while utilizing some of the higher cost inventory on hand.  Pass-through is a key strategic focus of Magnequench and ensures that Magnequench focuses on generating long term sustainable and value-added margins.

CHEMICALS & OXIDES ("C&O") SEGMENT RESULTS

TABLE 3: Selected C&O Results
	Year-over-Year Comparison
($000s)	Q1 2023	Q1 2022
Revenue	51,289	67,662
Operating (loss) income	(6,126)	18,477
EBITDA^(1)	(5,523)	18,968
Adjusted EBITDA^(1)	(4,562)	19,910

_________________________

⁽¹⁾Neo reports non-IFRS measures such as "Adjusted Net Income", "Adjusted Earnings per Share", "Adjusted EBITDA", "Adjusted EBITDA Margin" and "EBITDA". Please see information on this and other non-IFRS measures in the "Non-IFRS Measures" section of this news release and in the MD&A.

The C&O segment was negatively impacted by a steep decline in rare earth prices during the quarter.  Rare earth finished good prices, particularly for the magnetic elements, declined 20%-30% from December 2022.  This rapid decline had a negative impact on rare earth separation margins as C&O processed raw materials purchased three to five months ago (at higher raw material input costs).  The rapid decline, primarily in March 2023, also necessitated C&O to record a $6.4 million provision for inventories in the first quarter of 2023.  Volumes in rare earth separation were also slower in the quarter related to the slow down in the magnetics industry in China.

Volumes in the emissions catalyst business were down slightly from prior year with a significant decline in volumes in China (for the reasons noted above) while other regions demonstrating growth.  C&O's environmentally protective water treatment solutions business continues to perform well with higher volume and new customer adoption. 

RARE METALS SEGMENT RESULTS

TABLE 4: Selected Rare Metals Results
	Year-over-Year Comparison
($000s)	Q1 2023	Q1 2022
Revenue	29,076	29,062
Operating income	5,832	3,723
EBITDA^(1)	5,207	4,512
Adjusted EBITDA^(1)	6,164	4,341

_________________________

⁽¹⁾Neo reports non-IFRS measures such as "Adjusted Net Income", "Adjusted Earnings per Share", "Adjusted EBITDA", "Adjusted EBITDA Margin" and "EBITDA". Please see information on this and other non-IFRS measures in the "Non-IFRS Measures" section of this news release and in the MD&A.

Rare Metals continued its strong earnings growth trend with a strong first quarter of 2023.  Hafnium pricing, in particular, has continued its upward trajectory which began in the fourth quarter of 2021.  The recycling purchases and activities of Rare Metals were particularly impactful to maintaining lower raw material costs resulting in additional margins. 

The Rare Metals business continues to make progress in several key strategic initiatives, including selling more products outside of the aerospace industry, expanding its customer base, and diversifying its total end-market exposure.  Key progress continues to be made in expanding the capacity of key products (with minimal capital investment) and refocusing the sales pipeline and manufacturing capacity toward more profitable end products that require higher purity and more demanding specifications.   

CONFERENCE CALL ON FRIDAY MAY 12, 2023 AT 10 AM EASTERN

Management will host a teleconference call on Friday May 12, 2023 at 10:00 a.m. (Eastern Time) to discuss the first quarter 2023 results.  Interested parties may access the teleconference by calling [phone] (local) or  [phone] (toll-free long distance) or by visiting http://cnw.en.mediaroom.com/events.  A recording of the teleconference may be accessed by calling [phone] (local) or [phone] (toll-free long distance), and entering pass code 029840# until June 12, 2023.

NON-IFRS MEASURES

This news release refers to certain non-IFRS financial measures and ratios such as "Adjusted Net Income", "EBITDA", "Adjusted EBITDA", and "Adjusted EBITDA Margin".  These measures and ratios are not recognized measures under IFRS, do not have a standardized meaning prescribed by IFRS, and may not be comparable to similar measures presented by other companies. Rather, these measures and ratios are provided as additional information to complement IFRS financial measures by providing further understanding of Neo's results of operations from management's perspective. Neo's definitions of non-IFRS measures used in this news release may not be the same as the definitions for such measures used by other companies in their reporting.  Non-IFRS measures and ratios have limitations as analytical tools and should not be considered in isolation nor as a substitute for analysis of Neo's financial information reported under IFRS.  Neo uses non-IFRS financial measures and ratios to provide investors with supplemental measures of its base-line operating performance and to eliminate items that have less bearing on operating performance or operating conditions and thus highlight trends in its core business that may not otherwise be apparent when relying solely on IFRS financial measures.  Neo believes that securities analysts, investors and other interested parties frequently use non-IFRS financial measures and ratios in the evaluation of issuers.  Neo's management also uses non-IFRS financial measures in order to facilitate operating performance comparisons from period to period. For definitions of how Neo defines such financial measures and ratios, please see the "Non-IFRS Financial Measures" section of Neo's management's discussion and analysis filing for the three months ended March 31, 2023, available on Neo's web site at www.neomaterials.com and on SEDAR at www.sedar.com.

TABLE 5: CONSOLIDATED STATEMENTS OF FINANCIAL POSITION

($000s)		March 31, 2023		December 31, 2022
ASSETS
Current
Cash and cash equivalents		$             145,742		$                    147,491
Restricted cash		1,192		1,179
Accounts receivable		65,998		81,409
Inventories		187,646		212,702
Income taxes receivable		1,260		355
Other current assets		29,788		23,279
Total current assets		431,626		466,415
Property, plant and equipment		78,162		75,767
Intangible assets		42,198		42,984
Goodwill		66,613		66,042
Investments		15,994		16,363
Deferred tax assets		8,706		6,956
Other non-current assets		1,531		1,933
Total non-current assets		213,204		210,045
Total assets		$             644,830		$                    676,460
LIABILITIES AND EQUITY
Current
Bank advances and other short-term debt		$                  3,222		$                      17,288
Accounts payable and other accrued charges		57,765		69,093
Income taxes payable		9,097		10,033
Provisions		1,347		1,369
Lease obligations		1,394		1,264
Derivative liability		31,990		28,570
Current portion of long-term debt		763		747
Other current liabilities		599		278
Total current liabilities		106,177		128,642
Long-term debt		29,902		29,885
Employee benefits		473		489
Provisions		24,387		23,604
Deferred tax liabilities		14,207		13,942
Lease obligations		1,544		813
Other non-current liabilities		1,443		1,442
Total non-current liabilities		71,956		70,175
Total liabilities		178,133		198,817
Non-controlling interest		2,949		3,193
Equity attributable to equity holders of Neo Performance Materials Inc.		463,748		474,450
Total equity		466,697		477,643
Total liabilities and equity		$             644,830		$                    676,460

____________________________

See accompanying notes to this table in Neo's Interim Condensed Consolidated Financial Statements for the Three Months Ended March 31, 2023, available on Neo's website at www.neomaterials.com and on SEDAR at www.sedar.com.

TABLE 6: CONSOLIDATED RESULTS OF OPERATIONS

Comparison of the three months ended March 31, 2023 to the three months ended March 31, 2022:

($000s)		Three Months Ended March 31,
		2023		2022
Revenue		$         135,530		$         166,282
Costs of sales
Costs excluding depreciation and amortization		116,621		114,316
Depreciation and amortization		2,168		2,378
Gross profit		16,741		49,588
Expenses
Selling, general and administrative		14,871		14,252
Share-based compensation		850		181
Depreciation and amortization		1,766		1,896
Research and development		3,251		4,574
		20,738		20,903
Operating (loss) income		(3,997)		28,685
Other expense		(478)		(433)
Finance cost, net		(4,012)		(414)
Foreign exchange loss		(580)		(411)
(Loss) income from operations before income taxes and equity income of associates		(9,067)		27,427
Income tax expense		(1,610)		(5,995)
(Loss) income from operations before equity income of associates		(10,677)		21,432
Equity (loss) income of associates (net of income tax)		(23)		1,269
Net (loss) income		$          (10,700)		$           22,701
Attributable to:
Equity holders of Neo		$          (10,454)		$           22,350
Non-controlling interest		(246)		351
		$          (10,700)		$           22,701
(Loss) earnings per share attributable to equity holders of Neo:
Basic		$              (0.23)		$                0.55
Diluted		$              (0.23)		$                0.54

____________________________

See Management's Discussion and Analysis for the Three Months Ended March 31, 2023, available on Neo's website at www.neomaterials.com and on SEDAR at www.sedar.com.

TABLE 7: RECONCILIATION OF NET (LOSS) INCOME TO EBITDA, ADJUSTED EBITDA AND FREE CASH FLOW

($000s)		Three Months Ended March 31,
		2023		2022
Net (loss) income		$        (10,700)		$          22,701
Add back (deduct):
Finance cost, net		4,012		414
Income tax expense		1,610		5,995
Depreciation and amortization included in costs of sales		2,168		2,378
Depreciation and amortization included in operating expenses		1,766		1,896
EBITDA		(1,144)		33,384
Adjustments to EBITDA:
Other expense ^(1)		478		433
Foreign exchange loss ^(2)		580		411
Equity loss (income) of associates		23		(1,269)
Share-based compensation ^(3)		850		181
Other recoveries  ^(4)		—		(22)
Adjusted EBITDA ^(5)		$               787		$          33,118
Adjusted EBITDA Margins ^(5)		0.6 %		19.9 %
Less:
Capital expenditures		$            5,016		$            6,782
Free Cash Flow ^(5)		$          (4,229)		$          26,336
Free Cash Flow Conversion^(5)		(537.4 %)		79.5 %

Notes:
(1)	Represents other expenses resulting from non-operational related activities, including provisions for damages for outstanding legal claims related to historic volumes.  These costs and recoveries are not indicative of Neo's ongoing activities.
(2)	Represents unrealized and realized foreign exchange losses (gains) that include non-cash adjustments in translating foreign denominated monetary assets and liabilities.
(3)	Represents share-based compensation expense in respect of the Plan and the LTIP.
(4)	These represent primarily legal, professional advisory fees and other transaction costs incurred with respect to non-operating capital structure related transactions.  Neo has removed these charges to provide comparability with historic periods.
(5)	Neo reports non-IFRS measures such as "Adjusted Net Income", "Adjusted Earnings per Share", "Adjusted EBITDA", "Adjusted EBITDA Margin", "Free Cash Flow" and "Free Cash Flow Conversion". Please see information on this and other non-IFRS measures in the "Non-IFRS Measures" section of this new release and in the MD&A, available on Neo's website www.neomaterials.com and on SEDAR at www.sedar.com.

TABLE 8: RECONCILIATION OF NET (LOSS) INCOME TO ADJUSTED NET (LOSS) INCOME

($000s)		Three Months Ended March 31,
		2023		2022
Net (loss) income		$          (10,700)		$           22,701
Adjustments to net (loss) income:
Foreign exchange loss ^(1)		580		411
Share-based compensation ^(2)		850		181
Other recoveries ^(3)		—		(22)
Other items included in other expense ^(4)		407		547
Tax impact of the above items		(118)		(353)
Adjusted net (loss) income^(5)		$            (8,981)		$           23,465
Attributable to:
Equity holders of Neo		$            (8,735)		$           23,114
Non-controlling interest		$               (246)		$                 351
Weighted average number of common shares outstanding:
Basic		45,196,921		40,681,191
Diluted		45,196,921		41,149,323
Adjusted earnings (loss) per share ^(5) attributable to equity holders of Neo:
Basic		$               (0.19)		$                 0.57
Diluted		$               (0.19)		$                 0.56

Notes:
(1)	Represents unrealized and realized foreign exchange losses (gains) that include non-cash adjustments in translating foreign denominated monetary assets and liabilities.
(2)	Represents share-based compensation expense in respect of the Plan and the LTIP.
(3)	These represent primarily legal, professional advisory fees and other transaction costs incurred with respect to non-operating capital structure related transactions.  Neo has removed these charges to provide comparability with historic periods.
(4)	Represents other expenses resulting from non-operational related activities, including provisions for damages for outstanding legal claims related to historic volumes.  These costs and recoveries are not indicative of Neo's ongoing activities.
(5)	Neo reports non-IFRS measures such as "Adjusted Net Income", "Adjusted Earnings per Share", "Adjusted EBITDA", "Adjusted EBITDA Margin", "Free Cash Flow" and "Free Cash Flow Conversion". Please see information on this and other non-IFRS measures in the "Non-IFRS Measures" section of this new release and in the MD&A, available on Neo's website www.neomaterials.com and on SEDAR at www.sedar.com.

About Neo Performance Materials

Neo manufactures the building blocks of many modern technologies that enhance efficiency and sustainability.  Neo's advanced industrial materials - magnetic powders and magnets, specialty chemicals, metals, and alloys - are critical to the performance of many everyday products and emerging technologies. Neo's products help to deliver the technologies of tomorrow to consumers today.  The business of Neo is organized along three segments: Magnequench, Chemicals & Oxides and Rare Metals. Neo is headquartered in Toronto, Ontario, Canada; with corporate offices in Greenwood Village, Colorado, United States; Singapore; and Beijing, China. Neo has a global platform that includes 9 manufacturing facilities located in China, the United States, Germany, Canada, Estonia, and Thailand, as well as one dedicated research and development centre in Singapore.  For more information, please visit www.neomaterials.com.

Cautionary Statements Regarding Forward Looking Statements

This news release contains "forward-looking information" within the meaning of applicable securities laws in Canada. Forward-looking information may relate to future events or future performance of Neo. All statements in this release, other than statements of historical facts, with respect to Neo's objectives and goals, as well as statements with respect to its beliefs, plans, objectives, expectations, anticipations, estimates, and intentions, are forward-looking information. Specific forward-looking statements in this discussion include, but are not limited to, the following: expectations regarding certain of Neo's future results and information, including, among other things, revenue, expenses, sales growth, capital expenditures, and operations; statements with respect to current and future market trends that may directly or indirectly impact sales and revenue of Neo; expected use of cash balances; continuation of prudent management of working capital; source of funds for ongoing business requirements and capital investments; expectations regarding sufficiency of the allowance for uncollectible accounts and inventory provisions; analysis regarding sensitivity of the business to changes in exchange rates; impact of recently adopted accounting pronouncements; risk factors relating to intellectual property protection and intellectual property litigation; risk factors relating to national or international economies (including the impact of COVID-19), and other risks present in the jurisdictions in which Neo, its customers, its suppliers, and/or its logistics partners operate, and; expectations concerning any remediation efforts to Neo's design of its internal controls over financial reporting and disclosure controls and procedures. Often, but not always, forward-looking information can be identified by the use of words such as "plans", "expects", "is expected", "budget", "scheduled", "estimates", "continues", "forecasts", "projects", "predicts", "intends", "anticipates" or "believes", or variations of, or the negatives of, such words and phrases, or state that certain actions, events or results "may", "could", "would", "should", "might" or "will" be taken, occur or be achieved. This information involves known and unknown risks, uncertainties and other factors that may cause actual results or events to differ materially from those anticipated in such forward-looking information. Neo believes the expectations reflected in such forward-looking information are reasonable, but no assurance can be given that these expectations will prove to be correct and such forward-looking information included in this discussion and analysis should not be unduly relied upon. For more information on Neo, investors should review Neo's continuous disclosure filings that are available under Neo's profile at www.sedar.com.

SOURCE Neo Performance Materials, Inc.

Ali Mahdavi, SVP, Corporate Development & Capital Markets, [phone], Email: [email protected]; Jim Sims, Director of Corporate Communications, [phone], Email: [email protected], Website: www.neomaterials.com, Email: [email protected]